Article abstract


Nature Cell Biology 9, 1273 - 1285 (2007)
Published online: 21 October 2007 | doi:10.1038/ncb1647

A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-big gamma transactivation

Ichiro Takada1, Masatomo Mihara1,3, Miyuki Suzawa1, Fumiaki Ohtake1,2, Shinji Kobayashi1,2, Mamoru Igarashi1, Min-Young Youn1, Ken-ichi Takeyama1, Takashi Nakamura1,2, Yoshihiro Mezaki1, Shinichiro Takezawa1, Yoshiko Yogiashi1, Hirochika Kitagawa1, Gen Yamada4, Shinji Takada5, Yasuhiro Minami6, Hiroshi Shibuya7, Kunihiro Matsumoto8 & Shigeaki Kato1,2


Histone modifications induced by activated signalling cascades are crucial to cell-lineage decisions. Osteoblast and adipocyte differentiation from common mesenchymal stem cells is under transcriptional control by numerous factors. Although PPAR-gamma (peroxisome proliferator activated receptor-gamma) has been established as a prime inducer of adipogenesis, cellular signalling factors that determine cell lineage in bone marrow remain generally unknown. Here, we show that the non-canonical Wnt pathway through CaMKII–TAK1–TAB2–NLK transcriptionally represses PPAR-gamma transactivation and induces Runx2 expression, promoting osteoblastogenesis in preference to adipogenesis in bone marrow mesenchymal progenitors. Wnt-5a activates NLK (Nemo-like kinase), which in turn phosphorylates a histone methyltransferase, SETDB1 (SET domain bifurcated 1), leading to the formation of a co-repressor complex that inactivates PPAR-gamma function through histone H3-K9 methylation. These findings suggest that the non-canonical Wnt signalling pathway suppresses PPAR-gamma function through chromatin inactivation triggered by recruitment of a repressing histone methyltransferase, thus leading to an osteoblastic cell lineage from mesenchymal stem cells.

Top
  1. Institute of Molecular and Cellular Biosciences, University of Tokyo, Yayoi 1-1-1, Bunkyo-ku, Tokyo 113-0032, Japan.
  2. ERATO, Japan Science and Technology, Honcho 4-1-8, Kawaguchi, Saitama 332-0012, Japan.
  3. Department of Medicine and Bioregulatory Sciences, Institute of Health Biosciences, University of Tokushima Graduate School, Kuramoto-3, Tokushima, 770-8503, Japan.
  4. Center for Animal Resources and Development (CARD), Graduate School of Medical and Pharmaceutical Sciences, Kumamoto University, Honjo 2-2-1, Kumamoto 860-0811, Japan.
  5. Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences, Okazaki, Aichi 444-8787, Japan.
  6. Department of Genome Sciences, Graduate School of Medicine, Kobe University, Kobe 650-0017, Japan.
  7. Department of Molecular Cell Biology, Medical Research Institute and School of Biomedical Science, Tokyo Medical and Dental University, and CREST, JST, Kanda-Surugadai, Chiyoda-kuM, Tokyo 101-0062, Japan.
  8. Department of Molecular Biology, Graduate School of Science, Nagoya University, Chikusa-ku, Nagoya 464-8602, Japan.

Correspondence to: Shigeaki Kato1,2 e-mail: uskato@mail.ecc.u-tokyo.ac.jp



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

Fat or bone? A non-canonical decision

Nature Cell Biology News and Views (01 Nov 2007)


Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Open Innovation Challenges

naturejobs